Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes

MLA

Jerry R. Greenfield, et al. “Metabolic Dysfunction-Associated Fatty Liver Disease and Insulin Resistance in Type 1 Diabetes.” The Lancet. Gastroenterologyhepatology, vol. 6, no. 12, Sept. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bb1bd6a3318adaf53b56ac98091cb20e&authtype=sso&custid=ns315887.

APA

Jerry R. Greenfield, Jennifer R Snaith, & Mark Danta. (2021). Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes. The Lancet. Gastroenterologyhepatology, 6(12).

Chicago

Jerry R. Greenfield, Jennifer R Snaith, and Mark Danta. 2021. “Metabolic Dysfunction-Associated Fatty Liver Disease and Insulin Resistance in Type 1 Diabetes.” The Lancet. Gastroenterologyhepatology 6 (12). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bb1bd6a3318adaf53b56ac98091cb20e&authtype=sso&custid=ns315887.